Viewing Study NCT00062205


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-05-20 @ 3:25 PM
Study NCT ID: NCT00062205
Status: COMPLETED
Last Update Posted: 2010-02-09
First Post: 2003-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor View